Company profile MNPR
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 120 inf% YoY inf% QoQ |
| 2021 | 136 inf% YoY 13.3% QoQ | 156 inf% YoY 14.7% QoQ | 262 inf% YoY 67.9% QoQ | 185 54.2% YoY -29.4% QoQ |
| 2022 | 53 -61.0% YoY -71.4% QoQ | 212 35.9% YoY 300.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Monopar Therapeutics was 4.31 per week. The last year interest of Monopar Therapeutics compared to the last 5 years has changed by -100.0%. This is something to be checked. This didn't exist 5 years ago.
After 34 days of this quarter the interest is at 422.0. Based on that we can calculate that during remaining 58 days it will total up to 1142.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 544 |
| 2019 | 956 75.7% QoQ | 951 -0.5% QoQ | 914 -3.9% QoQ | 975 79.2% YoY 6.7% QoQ |
| 2020 | 990 3.6% YoY 1.5% QoQ | 814 -14.4% YoY -17.8% QoQ | 936 2.4% YoY 15.0% QoQ | 929 -4.7% YoY -0.7% QoQ |
| 2021 | 869 -12.2% YoY -6.5% QoQ | 915 12.4% YoY 5.3% QoQ | 951 1.6% YoY 3.9% QoQ | 917 -1.3% YoY -3.6% QoQ |
| 2022 | 886 2.0% YoY -3.4% QoQ | 897 -2.0% YoY 1.2% QoQ | 859 -9.7% YoY -4.2% QoQ | 860 -6.2% YoY 0.1% QoQ |
| 2023 | 947 6.9% YoY 10.1% QoQ | 946 5.5% YoY -0.1% QoQ | 900 4.8% YoY -4.9% QoQ | 422 -50.9% YoY -53.1% QoQ |
The average 5 years interest of cancer treatment was 70.41 per week. The last year interest of cancer treatment compared to the last 5 years has changed by 0.24%. The interest for cancer treatment is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -1.58%.
There is not enough data for Validive clinical trial to provide analysis
There is not enough data for Validive clinical trial to provide correlation calculation
There is not enough data for Validive clinical trial to provide analysis
After 39 days of this quarter the interest is at 108.0. Based on that we can calculate that during remaining 52 days it will total up to 252.0. chemoradiotherapy expected interest is significantly higher compared to previous quarter (+113.6%) and same quarter last year (+245.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 50 | 61 22.0% QoQ | 97 59.0% QoQ | 50 -48.5% QoQ |
| 2020 | 41 -18.0% YoY -18.0% QoQ | 87 42.6% YoY 112.2% QoQ | 71 -26.8% YoY -18.4% QoQ | 66 32.0% YoY -7.0% QoQ |
| 2021 | 76 85.4% YoY 15.2% QoQ | 18 -79.3% YoY -76.3% QoQ | 30 -57.7% YoY 66.7% QoQ | 71 7.6% YoY 136.7% QoQ |
| 2022 | 68 -10.5% YoY -4.2% QoQ | 88 388.9% YoY 29.4% QoQ | 47 56.7% YoY -46.6% QoQ | 80 12.7% YoY 70.2% QoQ |
| 2023 | 73 7.4% YoY -8.8% QoQ | 52 -40.9% YoY -28.8% QoQ | 74 57.4% YoY 42.3% QoQ | 118 47.5% YoY 59.5% QoQ |
| 2024 | 108 47.9% YoY -8.5% QoQ | - | - | - |
The average 5 years interest of chemoradiotherapy was 5.46 per week. The last year interest of chemoradiotherapy compared to the last 5 years has changed by 34.62%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 37.9%.
There is not enough data for clonidine hydrochloride mucobuccal tablet to provide analysis
There is not enough data for clonidine hydrochloride mucobuccal tablet to provide correlation calculation
There is not enough data for clonidine hydrochloride mucobuccal tablet to provide analysis
There is not enough data for severe oral mucositis to provide analysis
There is not enough data for severe oral mucositis to provide correlation calculation
There is not enough data for severe oral mucositis to provide analysis
After 39 days of this quarter the interest is at 132.0. Based on that we can calculate that during remaining 52 days it will total up to 308.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 181 | 281 55.2% QoQ | 279 -0.7% QoQ | 327 17.2% QoQ |
| 2020 | 323 78.5% YoY -1.2% QoQ | 296 5.3% YoY -8.4% QoQ | 305 9.3% YoY 3.0% QoQ | 274 -16.2% YoY -10.2% QoQ |
| 2021 | 371 14.9% YoY 35.4% QoQ | 406 37.2% YoY 9.4% QoQ | 324 6.2% YoY -20.2% QoQ | 304 10.9% YoY -6.2% QoQ |
| 2022 | 373 0.5% YoY 22.7% QoQ | 345 -15.0% YoY -7.5% QoQ | 325 0.3% YoY -5.8% QoQ | 252 -17.1% YoY -22.5% QoQ |
| 2023 | 310 -16.9% YoY 23.0% QoQ | 446 29.3% YoY 43.9% QoQ | 369 13.5% YoY -17.3% QoQ | 360 42.9% YoY -2.4% QoQ |
| 2024 | 132 -57.4% YoY -63.3% QoQ | - | - | - |
The average 5 years interest of oropharyngeal cancer was 25.22 per week. The last year interest of oropharyngeal cancer compared to the last 5 years has changed by 12.01%. The interest for oropharyngeal cancer is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 22.93%.
There is not enough data for Camsirubicin to provide analysis
There is not enough data for Camsirubicin to provide correlation calculation
There is not enough data for Camsirubicin to provide analysis
After 39 days of this quarter the interest is at 296.0. Based on that we can calculate that during remaining 52 days it will total up to 691.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 496 | 926 86.7% QoQ | 892 -3.7% QoQ | 853 -4.4% QoQ |
| 2020 | 844 70.2% YoY -1.1% QoQ | 794 -14.3% YoY -5.9% QoQ | 964 8.1% YoY 21.4% QoQ | 826 -3.2% YoY -14.3% QoQ |
| 2021 | 772 -8.5% YoY -6.5% QoQ | 778 -2.0% YoY 0.8% QoQ | 907 -5.9% YoY 16.6% QoQ | 762 -7.7% YoY -16.0% QoQ |
| 2022 | 888 15.0% YoY 16.5% QoQ | 855 9.9% YoY -3.7% QoQ | 972 7.2% YoY 13.7% QoQ | 924 21.3% YoY -4.9% QoQ |
| 2023 | 935 5.3% YoY 1.2% QoQ | 881 3.0% YoY -5.8% QoQ | 905 -6.9% YoY 2.7% QoQ | 842 -8.9% YoY -7.0% QoQ |
| 2024 | 296 -68.3% YoY -64.8% QoQ | - | - | - |
The average 5 years interest of soft tissue sarcoma was 66.33 per week. The last year interest of soft tissue sarcoma compared to the last 5 years has changed by -0.9%. The interest for soft tissue sarcoma is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -3.64%.
There is not enough data for MNPR-101 to provide analysis
There is not enough data for MNPR-101 to provide correlation calculation
There is not enough data for MNPR-101 to provide analysis
There is not enough data for urokinase plasminogen activator receptor targeted antibody to provide analysis
There is not enough data for urokinase plasminogen activator receptor targeted antibody to provide correlation calculation
There is not enough data for urokinase plasminogen activator receptor targeted antibody to provide analysis
There is not enough data for MNPR-101 RIT to provide analysis
There is not enough data for MNPR-101 RIT to provide correlation calculation
There is not enough data for MNPR-101 RIT to provide analysis
There is not enough data for radioimmunotherapeutic to provide analysis
There is not enough data for radioimmunotherapeutic to provide correlation calculation
There is not enough data for radioimmunotherapeutic to provide analysis
After 39 days of this quarter the interest is at 80.0. Based on that we can calculate that during remaining 52 days it will total up to 187.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 14 | 16 14.3% QoQ | 20 25.0% QoQ | 13 -35.0% QoQ |
| 2020 | 342 2342.9% YoY 2530.8% QoQ | 716 4375.0% YoY 109.4% QoQ | 535 2575.0% YoY -25.3% QoQ | 519 3892.3% YoY -3.0% QoQ |
| 2021 | 685 100.3% YoY 32.0% QoQ | 348 -51.4% YoY -49.2% QoQ | 528 -1.3% YoY 51.7% QoQ | 429 -17.3% YoY -18.8% QoQ |
| 2022 | 426 -37.8% YoY -0.7% QoQ | 270 -22.4% YoY -36.6% QoQ | 285 -46.0% YoY 5.6% QoQ | 206 -52.0% YoY -27.7% QoQ |
| 2023 | 149 -65.0% YoY -27.7% QoQ | 109 -59.6% YoY -26.8% QoQ | 129 -54.7% YoY 18.3% QoQ | 143 -30.6% YoY 10.9% QoQ |
| 2024 | 80 -46.3% YoY -44.1% QoQ | - | - | - |
The average 5 years interest of severe COVID-19 was 22.84 per week. The last year interest of severe COVID-19 compared to the last 5 years has changed by -53.94%. The interest for severe COVID-19 is significantly decreasing. The last year interest is quite higher compared to 5 years ago. It has increased by 565.82%.
There is not enough data for MNPR-202 to provide analysis
There is not enough data for MNPR-202 to provide correlation calculation
There is not enough data for MNPR-202 to provide analysis
There is not enough data for doxorubicin-resistant cancers to provide analysis
There is not enough data for doxorubicin-resistant cancers to provide correlation calculation
There is not enough data for doxorubicin-resistant cancers to provide analysis
There is not enough data for Grupo Español de Investigación en Sarcomas to provide analysis
There is not enough data for Grupo Español de Investigación en Sarcomas to provide correlation calculation
There is not enough data for Grupo Español de Investigación en Sarcomas to provide analysis
After 39 days of this quarter the interest is at 68.0. Based on that we can calculate that during remaining 52 days it will total up to 159.0. NorthStar Medical Radioisotopes expected interest is significantly lower compared to previous quarter (-47.9%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 207 | 143 -30.9% QoQ | 193 35.0% QoQ | 234 21.2% QoQ |
| 2020 | 130 -37.2% YoY -44.4% QoQ | 110 -23.1% YoY -15.4% QoQ | 256 32.6% YoY 132.7% QoQ | 188 -19.7% YoY -26.6% QoQ |
| 2021 | 88 -32.3% YoY -53.2% QoQ | 117 6.4% YoY 33.0% QoQ | 74 -71.1% YoY -36.8% QoQ | 299 59.0% YoY 304.1% QoQ |
| 2022 | 264 200.0% YoY -11.7% QoQ | 88 -24.8% YoY -66.7% QoQ | 445 501.4% YoY 405.7% QoQ | 201 -32.8% YoY -54.8% QoQ |
| 2023 | 122 -53.8% YoY -39.3% QoQ | 90 2.3% YoY -26.2% QoQ | 116 -73.9% YoY 28.9% QoQ | 305 51.7% YoY 162.9% QoQ |
| 2024 | 68 -44.3% YoY -77.7% QoQ | - | - | - |
The average 5 years interest of NorthStar Medical Radioisotopes was 14.32 per week. The last year interest of NorthStar Medical Radioisotopes compared to the last 5 years has changed by -11.1%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -14.79%.
There is not enough data for radio-immuno-therapeutics to provide analysis
There is not enough data for radio-immuno-therapeutics to provide correlation calculation
There is not enough data for radio-immuno-therapeutics to provide analysis
There is not enough data for Cancer Science Institute of Singapore to provide analysis
There is not enough data for Cancer Science Institute of Singapore to provide correlation calculation
There is not enough data for Cancer Science Institute of Singapore to provide analysis